Axcella Therapeutics Launches Clinical Program to Develop Treatment for Patients with Long COVID
Axcella Therapeutics (Nasdaq: AXLA), a clinical-stage biotechnology company pioneering a new approach to treat complex diseases using multi-targeted endogenous metabolic modulator (EMM) compositions, today...